lunes, 12 de agosto de 2024

Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00175-3/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz--_KR8QDYDG-e1GcCBG8LnLKAWEAqteV9c5OgYArHwDWeZbYqB5XN5H9J2135SRvoiqbsvtAuxN1BotDHGSc-tyBIgMwA&_hsmi=319615056&utm_content=319423428&utm_source=hs_email

No hay comentarios:

Publicar un comentario